Case study / Operating architecture

Specialty Infusion Market Intelligence

Specialty-access opportunity became a ranked account universe, geographic activation map, CRM-ready field motion, and working decision interface.

Return to verified work

Evidence register

What this case can support.

Evidence class: Operating architecture
Claim boundary: This is a market-intelligence and application build. Account counts and QA results describe the built system, not client adoption, booked pipeline, or realized infusion revenue.
Source basis: Public and provider-directory data
ICP, ZIP, account, and activation workbooks
Local application QA and demo artifacts

Case architecture

Ecosystem thesis

Infusion growth depends on more than identifying specialists. Drug mix, payer access, site-of-care economics, referral behavior, geography, provider density, patient travel, operational capacity, and account readiness have to be translated into one field system.

System path

01Public signal
02ICP universe
03ZIP heat
04Activation queue
05CRM motion

Executive decision brief

CEO question

What system did this work make more launchable, fundable, or scalable?

Operating answer

Market intelligence becomes valuable when it changes Monday morning: who the team pursues, where it launches, what it validates, and how leadership sees the motion.

Proof to inspect

The proof is the built intelligence system and its verified scope: thousands of normalized accounts and locations, prioritized activation lanes, a working interface, and clean QA. It is not a claim of client adoption or booked revenue.

Ecosystem context

The outcome only makes sense inside the system around it.

A raw provider list hides the decisions a market team actually needs to make: which accounts matter, which ZIPs can support access, which specialties and therapies create a viable wedge, and what sequence turns market interest into a functioning referral corridor.

The build created a complete growth-intelligence layer rather than another market report. It connected account discovery, source lineage, ZIP opportunity, tiering, activation sequencing, CRM workflow, and executive visibility.

Because the source data is public or proxy-based, the system makes its boundary explicit: it guides market development and prioritization while reserving claims-based utilization conclusions for future validation.

Outcome record

The proof signals attached to the case.

analytics4,956 accounts

ICP universe

A source-aware specialty-access target universe.

growth244 A/B

Activation queue

Priority accounts separated from broad market coverage.

analytics195 ZIPs

Opportunity map

Geographic density translated into launch sequence.

operationsClean pass

Application QA

No console errors or failed requests in the recorded validation.

Interoperability map

How the layers connect.

The case is designed as an operating ecosystem: signal, economics, workflow, proof, and expansion are connected rather than treated as separate workstreams.

ICP Universe

Which accounts belong in the market?

Public provider and location data were normalized into a 4,956-account decision universe.

Opportunity Geography

Where can access and density support launch?

ZIP-level opportunity and provider-location layers made geographic concentration visible.

Activation Motion

Who moves first, and what happens next?

A/B tiers, a 12-week queue, next actions, and CRM states translated research into field cadence.

Decision Product

Can leadership inspect and govern the motion?

A working application connected account building, market maps, pipeline, QA, and executive visibility.

Operating record

The work, the sequence, and the strategic read.

The record separates the conditions, operating moves, interpretation, and repeatable lessons so the result can be evaluated without flattening the work into a headline.

Challenge

Replace a broad specialty-infusion market thesis with a precise, source-aware system that a growth team could use to prioritize geography, accounts, therapies, and next actions.

Approach

Built a market-intelligence application and operating dataset spanning ICP definition, ZIP opportunity, provider locations, target tiers, activation sequencing, CRM pipeline, and QA.

Founder takeaway

Market intelligence becomes valuable when it changes Monday morning: who the team pursues, where it launches, what it validates, and how leadership sees the motion.

Strategic read

This case demonstrates integrated consulting and product delivery. The answer was not only a market recommendation; it was a usable growth-intelligence product with operating boundaries and field logic.

Proof interpretation

Operator moves

Structured a 4,956-account ICP universe and a 244-account A/B activation queue.
Mapped 195 ZIP opportunity zones and more than 9,000 public provider-location rows.
Created a 160-account activation plan and a 500-account CRM-ready pipeline.
Built account discovery, map, pipeline, and execution views into one working interface.
Validated the experience with no console errors or failed requests in the recorded QA pass.

Expansion path

01
Validate the top accounts and geography with local commercial evidence.
02
Add claims and payer data only under an explicit data-governance model.
03
Connect capacity, therapy, access, and site-of-care assumptions to account scoring.
04
Run the first 12-week activation cadence and measure progression quality.
05
Promote only repeatable market patterns into the expansion playbook.

What I would do again

Make source lineage visible beside every score.
Separate market potential from claims-validated utilization.
Design the CRM handoff while building the market map.

What this proves

Azis can move from healthcare market strategy through data architecture, UX, application delivery, and field execution design.

Start a serious conversation

Build the wedge. Prove the motion. Scale what repeats.

For Series A/B teams that need sales, partnerships, implementation, payer logic, and revenue intelligence to become one operating system.

Contact Azis Download Resume